Brief: Curasight Says Positive Results From The Phase 2 Study Of Utrace In Brain Cancer

Curasight A/S

14/09/2023 17:25

Sept 14 (Reuters) - Curasight A/S  CURAS.TE :
    * POSITIVE RESULTS FROM THE PHASE II STUDY OF UTRACE IN
BRAIN
CANCER PRESENTED AT THE WORLD MOLECULAR IMAGING CONGRESS (WMIC)
2023 IN PRAGUE

Source text for Eikon:  ID:nWkrc7hWfN 
Further company coverage:  CURAS.TE 

 ((Reuters.Briefs@thomsonreuters.com;;))